These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2877314)

  • 1. Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancer.
    Zielinski CC; Kubista E; Salzer H; Sevelda P; Langer M; Staffen A; Spona J; Aiginger P
    Lancet; 1986 Nov; 2(8516):1164. PubMed ID: 2877314
    [No Abstract]   [Full Text] [Related]  

  • 2. Eight-year follow-up of adjuvant therapy for stage II breast cancer.
    Hubay CA; Gordon NH; Pearson OH; Marshall JS; McGuire WL
    World J Surg; 1985 Oct; 9(5):738-49. PubMed ID: 3904231
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant therapy of breast cancer patients].
    Semiglazov VF; Bavli IaL; Moiseenko VM
    Vopr Onkol; 1986; 32(11):59-63. PubMed ID: 3097961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy in primary breast cancer.
    Wolmark N; Fisher B
    Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [No advantage to using the CMF-regimen for node positive, postmenopausal, receptor-positive mammary carcinoma with adjuvant tamoxifen therapy].
    Heidemann E
    Strahlenther Onkol; 1998 May; 174(5):290-1. PubMed ID: 9614963
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
    Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
    J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for early breast cancer.
    Costa SD; Bischoff J
    N Engl J Med; 2007 Mar; 356(12):1268-9. PubMed ID: 17377168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant tamoxifen and chemotherapy in stage II breast cancer: interim findings from NSABP protocol B-09.
    Wolmark N; Fisher B
    World J Surg; 1985 Oct; 9(5):750-5. PubMed ID: 3904232
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
    Goldhirsch A; Castiglione M; Gelber RD
    Lancet; 1990 May; 335(8697):1099-100. PubMed ID: 1970400
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolving concepts in the systemic adjuvant treatment of breast cancer.
    Bonadonna G
    Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
    J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
    Jonat W; Kaufmann M; Abel U
    Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
    [No Abstract]   [Full Text] [Related]  

  • 14. One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer.
    Ejlertsen B; Jensen MB; Elversang J; Rasmussen BB; Andersson M; Andersen J; Nielsen DL; Cold S; Mouridsen HT
    Eur J Cancer; 2013 Sep; 49(14):2986-94. PubMed ID: 23756360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer.
    Alagaratnam TT; Wong J
    Aust N Z J Surg; 1986 Jan; 56(1):39-41. PubMed ID: 3090987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.
    Pritchard KI; Paterson AH; Fine S; Paul NA; Zee B; Shepherd LE; Abu-Zahra H; Ragaz J; Knowling M; Levine MN; Verma S; Perrault D; Walde PL; Bramwell VH; Poljicak M; Boyd N; Warr D; Norris BD; Bowman D; Armitage GR; Weizel H; Buckman RA
    J Clin Oncol; 1997 Jun; 15(6):2302-11. PubMed ID: 9196144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
    Goldhirsch A; Gelber RD
    Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer].
    Semiglazov VF; Moiseenko VM; Ivanova OA
    Vopr Onkol; 1986; 32(8):31-4. PubMed ID: 3532535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tamoxifen in breast cancer.
    Gau TC
    Postgrad Med; 1985 Jun; 77(8):21-2. PubMed ID: 3839078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.